When it comes to discussing medication risks, a new study shows, rheumatologists and their patients are speaking different languages. The article reveals how doctors may be sending messages they don't intend.
Prior authorizations have begun to spread pandemic-like from high-cost biologics to treatments used routinely in rheumatology. The time burden on rheumatologists is insupportable, contends the author, who says it's time to take action.
Antinuclear antibody testing and DEXA both appear on a new Canadian list of rheumatology tests to avoid and on a similar 2013 list from the American College of Rheumatology. There are interesting differences in the other 3 choices.
Oral etidronate, IV pamidronate, and then zoledronate caused bone markers to normalize in this 80-year-old woman—temporarily. What’s going on? Answer this and questions on 3 other topics in this week’s quiz.
Positioning of the probe is "three-quarters of the battle" in diagnosing synovitis of the wrist or hand, says Dr. DeMarco in this video. But gel technique and pressure are crucial to gaining accurate clinical information from ultrasound imaging of this condition.
(ACR14) (VIDEO) In tests so far, the infliximab biosimilar BOW015, just approved in India, seems to look about the same to the human immune system as the original. Here, a VP of the company behind BOW015 talks about the realities of seeking approval in the US.
(ACR2014) (VIDEO) The National Institutes of Health's PROMIS measures, created to study health status in the general population, look good for meaningful outcomes assessment in diseases such as rheumatoid arthritis, says an expert who studies measurement of disability in rheumatic disorders..
(VIDEO) First, a live demonstration of ultrasound probe placement to examine the Achilles tendon for enthesitis. Then, a narrated series of still slides and films showing normal and abnormal views from the ultrasound monitor.